Healthcare -
Biotechnology - NASDAQ - US
$ 11.5216
-1.61 %
$ 467 M
Market Cap
-2.21
P/E
KROS - TOTAL OTHER INCOME
Total Other Income KROS - Keros Therapeutics, Inc.
16.9 M
LAST VALUE
600.58%
2 YEAR CAGR
94.24%
5 YEAR CAGR
0.00%
10 YEAR CAGR